Berk, Michael https://orcid.org/0000-0002-5554-6946
Agustini, Bruno
Woods, Robyn L.
Nelson, Mark R.
Shah, Raj C. https://orcid.org/0000-0001-9706-9730
Reid, Christopher M.
Storey, Elsdon
Fitzgerald, Sharyn M.
Lockery, Jessica E.
Wolfe, Rory
Mohebbi, Mohammadreza
Dodd, Seetal
Murray, Anne M.
Stocks, Nigel
Fitzgerald, Paul B.
Mazza, Catherine
McNeil, John J. https://orcid.org/0000-0002-1049-5129
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U01AG029824)
Department of Health | National Health and Medical Research Council (1081901, 334047, 1127060)
Article History
Received: 18 August 2020
Revised: 14 December 2020
Accepted: 7 January 2021
First Online: 27 January 2021
Compliance with ethical standards
:
: MB has received grant/research support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier—all unrelated to this work. PBF has received equipment for research from MagVenture A/S, Medtronic Ltd, Neuronetics and Brainsway Ltd and funding for research from Neuronetics. He is on scientific advisory boards for Bionomics Ltd and LivaNova and is a founder of TMS Clinics Australia: all unrelated to this work. MRN received travel and advisory board support from Bayer AG who provided product for the ASPREE study.